TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc.

No trades
See on Supercharts

RNAZ fundamentals

The current financial position of TransCode Therapeutics, Inc.

Total assets of RNAZ for Q3 24 is 3.94 M USD, 18.42% less than the previous Q2 24. And total liabilities decreased by 34.79% in Q3 24 to 2.28 M USD.

Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total assets
Total liabilities
Currency: USD
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Total assetsYoY growth
Total equityYoY growth